Bioanalysis of radioiodine labelled meta-iodobenzylguanidine, its metabolites and free radioiodide in body fluids

European Journal of Pharmaceutical Sciences

Volumn 5, Issue 2, 1997, Pages 97-108

  Wafelman, Amon R ^a,b,d   Hoefnagel, Cornelis A ^b   Maes, Robert A A ^c   Beijnen, Jos H ^a,b,c  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Metabolites; Plasma; Saliva; Urine; Whole blood; 123I 131I iodide; 123I 131I meta iodobenzylguanidine

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; DRUG METABOLITE; RADIOACTIVE IODINE;

ADULT; ARTICLE; BODY FLUID; CASE REPORT; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG SALIVA LEVEL; DRUG URINE LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

EID: 0030907188     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(97)00266-2     Document Type: Article

References (23)

1. 123I-metaiodobenzylguanidine. Eur. J. Nucl. Med. 15, 618-623.
2. Hoefnagel, C.A. (1991) Radionuclide therapy revisited. Eur. J. Nucl. Med. 18, 408-431.
3. Hoefnagel, C.A. (1994) Metaiodobenzylguanidine and somatosta tin in oncology: role in the management of neural crest tumours. Eur. J. Nucl. Med. 21, 561-581.
4. 131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis (MIBG de novo). J. Nucl. Biol. Med. 35, 248-251.
5. Ingersoll, A.W. and Babcock, S.H. (1943) Hippuric acid. Organic Syntheses (II) 5, 328-330.
6. 131]-iodine-metaiodobenzylguanidine in patients with metastatic pheochromocytoma. J. Nucl. Med. 27, 37-44.
7. Merlet, P., Valette, H., Dubois-Randé, J.L., Moyse, D., Duboc, D., Dove, P., Bourguignon, M.H., Benvenuti, C., Duval, A.M., Agostini, D., Loisance, D., Castaigne, A. and Syrota, A. (1992) Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J. Nucl. Med. 33, 471-477.
8. 131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas. Semin. Nucl. Med. 15, 154-160.
9. 131I]iodobenzylguanidine. J. Nucl. Med. 25, 2-6.
10. 131I]Metaiodobenzylguanidine: results from ten years of experience. J. Nucl. Biol. Med. 35, 269-276.
11. 123]-iodine-metaiodobenzylguanidine. J. Nucl. Med. 27, 1138-1142.
12. Streitwieser, A. Jr and Heathcock, C.H. (1976) Introduction to organic chemistry, 1st edn., Macmillan, New York, p. 391.
13. Valdés Olmos, R.A., ten Bokkel Huinink, W.W., Greve, J.C. and Hoefnagel, C.A. (1992) I-123 MIBG and serial radionuclide angiocardiography in doxorubicin-related cardiotoxicity. Clin. Nucl. Med. 17, 163-167.
14. Vogel, A.I. (1956) A text-book of practical organic chemistry: including qualitative organic analysis, 3rd edn., Longman, London, p. 692.
15. Vogel, A.I. (1961) A text-book of quantitative inorganic analysis: including elementary instrumental analysis, 3rd edn., Longman, London, p. 568.
16. Vree, T.B., Hekster, Y.A. and Anderson, P.G. (1992) Contribution of the human kidney to the metabolic clearance of drugs. Ann. Pharmacother. 26, 1421-1428.
17. 131I]MIBG infusion fluids; a report from clinical practice. Eur. J. Nucl. Med. 20, 614-616.
18. 131I]MIBG infusion fluids: a comparison and discussion of the chromatographic characteristics using three different techniques. Appl. Radiat. Isot. 44, 859-867.
19. Wafelman, A.R., Hoefnagel, C.A., Maes, R.A.A. and Beijnen, J.H. (1994) Radioiodinated metaiodobenzylguanidine, a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry. Eur. J. Nucl. Med. 21, 545-559.
20. Weast, R.C. (1974) Handbook of Chemistry and Physics, 55th edn. CRC Press, Cleveland.
21. 131I]Iodobenzylguanidine. J. Nucl. Med. 21, 349-353.
22. Wilson, C.O., Gisvold, O. and Doerge, R.F. (1977) Textbook of organic medicinal and pharmaceutical chemistry, 7th edn., JB Lippincott, Philadelphia, p. 75.
23. 123]-iodine-metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy. Eur. J. Nucl. Med. 19, 265-270.